Search results
Sep 15, 2023 · There are different types of treatment for intraocular melanoma. The most common treatment is surgery. Radiation therapy, photocoagulation, and thermotherapy may also be used to kill cancer cells in the eye. Learn more about the different treatment options for intraocular melanoma.
Aug 9, 2022 · Eye melanoma is a type of eye cancer. Learn about symptoms and treatments for this rare cancer. It's also called ocular melanoma or uveal melanoma.
May 12, 2023 · Intraocular (uveal) melanoma treatment options include observation, surgery, radiation therapy, and transpupillary thermotherapy. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent intraocular melanoma in this summary for clinicians.
May 11, 2021 · What are potential new treatments for uveal melanoma? There’s a new drug called tebentafusp that showed very promising results in a large phase III clinical trial involving people with metastatic uveal melanoma.
Oct 11, 2021 · 4. Treatment options in uveal melanoma and metastatic disease. The main goals of ocular melanoma treatment are to destroy the tumor, prevent recurrence and metastasis, and conserve vision.
As a rare cancer, there are few approved treatments for the disease. To help provide the best possible care, MD Anderson conducts trials for new uveal melanoma treatments including immunotherapy and targeted therapy. Trials also include efforts to reduce side effects from ocular radiation therapy.
Jan 4, 2023 · Treatment of primary uveal melanoma with radiotherapy, enucleation or other modalities achieves local control in more than 90% of patients, although 40% or more ultimately develop distant...
Apr 29, 2021 · The drug, tebentafusp, is a type of treatment called a bispecific fusion protein. It works by helping immune cells get close enough to cancer cells to attack them. The clinical trial evaluated the drug as an initial treatment for people with metastatic uveal melanoma .
On January 26, 2022, the U.S. Food and Drug Administration announced the approval of KIMMTRAK (tebentafusp-tebn), the first and only FDA-approved treatment for metastatic uveal melanoma, developed by Immunocore.
Aug 15, 2018 · Treatment is focused on completely removing the tumor with surgery and giving adjuvant treatment with radiation or topical chemotherapy (with interferon or Mitomycin-C) to reduce the likelihood of metastases (tumor spread).
